Dan Dischner | executive |
William Peters | executive |
Jason Gerberry | analyst |
Timothy Chiang | analyst |
David Amsellem | analyst |
Tony Marrs | executive |
Glen Santangelo | analyst |
Serge Belanger | analyst |
Greetings, and welcome to the Amphastar Pharmaceuticals' fourth quarter earnings call. [Operator Instructions] Please note that certain statements made during this call regarding matters that are not historical facts including, but not limited to, management's outlook or predictions for future performance are forward-looking statements. These statements are based solely on information that is now available to us. We encourage you to review the section entitled Forward-Looking Statements in the press release issued today in the presentation on the company's website. Also, please refer to our SEC filings, which can be found on our website and the SEC's website for a discussion of numerous factors that may impact our future performance.
We will also discuss certain non-GAAP measures.